| Ronald Wayne Pinkard, DPM | |
|
400 40th St, Ste 202, Oakland, CA 94609-2509 | |
| (510) 597-0283 | |
| Not Available |
| Full Name | Ronald Wayne Pinkard |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Primary Podiatric Medicine |
| Location | 400 40th St, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366655003 | NPI | - | NPPES |
| 000E24930 | Other | CA | MEDI-CAL ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | E-2493 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ronald Wayne Pinkard, DPM 201 E. 12th St, #308, Oakland, CA 94606-2243 Ph: (510) 597-0283 | Ronald Wayne Pinkard, DPM 400 40th St, Ste 202, Oakland, CA 94609-2509 Ph: (510) 597-0283 |
News Archive
Procedural sedation and analgesia is an essential element of care for children requiring painful procedures in the emergency department. The practice of combining ketamine and propofol, two common medications used in emergency departments, has become more popular. However, until recently, it was unclear whether this practice was superior to the use of either agent alone, especially in children.
MEDICREA announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market the PASS LP Iliac Fixation within the United States. This new Iliac Fixation supplements the PASS LP range, a ultra Low Profile Polyaxial Spine System launched recently.
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
For the first time to date, research published in the October edition of the Journal of Thoracic Oncology (JTO) sought to determine the use of chemotherapy in a contemporary, diverse non-small cell lung cancer (NSCLC) population encompassing all patient ages. Prior population-based studies have shown that only 20 to 30 percent of advanced lung cancer patients receive chemotherapy treatment.
› Verified 4 days ago
Joseph D. Dickinson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Junaid Khan, Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3100 Telegraph Ave, Oakland, CA 94609 Phone: 800-607-6377 | |
David Wang, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1375 | |
Dennis J Lyons, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4247 Mac Arthur Blvd., Oakland, CA 94619 Phone: 510-530-0840 Fax: 510-530-0873 | |
Jake Lee, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3772 Howe St, Howe St. Building, Ground Floor, Podiatry Department, Oakland, CA 94611 Phone: 510-752-1231 | |
Advanced Foot Clinic, Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2844 Summit St Ste 107, Oakland, CA 94609 Phone: 510-463-3888 Fax: 510-433-0130 | |
Dr. Jason D. Pollard, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 |